SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: tommysdad who wrote (3781)5/13/2001 8:20:33 PM
From: Jibacoa  Read Replies (1) | Respond to of 52153
 
To technology designed to identify drug-like compounds more efficiently than traditional drug discovery techniques.

Orchid has developed SNP-IT, its proprietary SNP analysis technology.

Arena has developed CART, designed to identify drug-like compounds by genetically altering receptors to mimic the biological response that occurs when the native ligand binds to the receptor.

Bernard


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News